Wednesday, September 26, 2018

FDA Warns of Potential Neurological Problems from Flea and Tick Medicine

Please read! If your pet is sensitive, small, elderly, liver disease, seizures, kidney disease or has a weakened immune system, flea products can be especially harmful. Not every pet has a reaction but some do.

  • The FDA is alerting pet owners and veterinarians of the potential for neurologic adverse events (such as muscle tremors, seizures or loss of coordination) in dogs and cats when treated with drugs that are in the isoxazoline class.
  • The FDA-approved drugs in this class are Bravecto, Credelio, Nexgard and Simparica. These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations.
  • Although these products have been safely used with many dogs and cats, pet owners should consult with their veterinarian to review their pet's medical history to determine whether a product in the isoxazoline class is appropriate for their pet.

courtesy of the FDA bulletin 
Updated: 09/21/2018